Sort   by:  
 Page size 
UnknownBlood-brain barrier P-glycoprotein function in healthy subjects and Alzheimer's disease patients: effect of polymorphisms in the ABCB1 gene.
Not available
S-EPMC3483228 | biostudies-literature
UnknownP-tau subgroups in AD relate to distinct amyloid production and synaptic integrity profiles.
Not available
S-EPMC9288016 | biostudies-literature
UnknownTau PET correlates with different Alzheimer's disease-related features compared to CSF and plasma p-tau biomarkers.
Not available
S-EPMC8350902 | biostudies-literature
UnknownRegional [18F]flortaucipir PET is more closely associated with disease severity than CSF p-tau in Alzheimer's disease.
Not available
S-EPMC7567681 | biostudies-literature
UnknownEvaluation of a novel immunoassay to detect p-tau Thr217 in the CSF to distinguish Alzheimer disease from other dementias.
Not available
S-EPMC7734919 | biostudies-literature
UnknownLonger Duration of Hypertension and MRI Microvascular Brain Alterations Are Associated with Lower Hippocampal Volumes in Older Individuals with Hypertension.
Not available
S-EPMC7175941 | biostudies-literature
UnknownEffect of obicetrapib, a potent cholesteryl ester transfer protein inhibitor, on p-tau217 levels in patients with cardiovascular disease.
Not available
S-EPMC12811769 | biostudies-literature
UnknownBrain white matter hyperintensities in Kawasaki disease: A case-control study.
Not available
S-EPMC9623056 | biostudies-literature
UnknownEfficacy of remote ischemic conditioning on improving WMHs and cognition in very elderly patients with intracranial atherosclerotic stenosis.
Not available
S-EPMC6366980 | biostudies-literature
UnknownWhite matter hyperintensities burden in the frontal regions is positively correlated to the freezing of gait in Parkinson's disease.
Not available
S-EPMC10172504 | biostudies-literature
Sort   by:  
 Page size